We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The founder of 23andMe , Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company, saying ...

A key decision by the bankruptcy judge could help with protecting consumer data, write Diane Lourdes Dick and Anya Prince.

It's only a matter of time before cybercriminals begin to use artificial intelligence-enabled tools, open-source software and ...

Regeneron Pharmaceuticals and a privacy ombudsman are raising concerns over a push by 23andMe’s co-founder to challenge the ...

Regeneron acquires 23andMe's genetics services for (Dollar) 256 million * Customer privacy safeguards will remain in place ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...

A federal judge in San Francisco on Friday issued an injunction, blocking President Donald Trump from laying off thousands of ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.